Core Viewpoint - The article discusses the development of the "Traditional Chinese Medicine Mass Spectrometry Identity Database" by Professor Li Yuber's team at Tianjin University of Traditional Chinese Medicine, aiming to advance the modernization of traditional Chinese medicine (TCM) and promote rational clinical use of TCM [2][5]. Group 1: Database Construction and Methodology - The core bottleneck in analyzing TCM components has been the lack of a large standardized spectral library for comparison, which the team addresses by creating a mass spectrometry identity database [5]. - The database has collected over 10,000 known standard samples, covering a wide range of TCM resources, enabling rapid identification and assisted judgment of TCM components [5][6]. - The construction of the database is supported by standardized data collection processes and consistent experimental conditions, transforming mass spectrometry from a detection tool to a scientific basis for identification and verification [6]. Group 2: Clinical Application and Technology Transfer - The team has expanded its research to include monitoring the safety of TCM use and industrial transformation, developing over 20 clinical test kits based on key metabolic indicators [8]. - The goal is to establish a complete system from detection and analysis to intervention, integrating instruments, software, databases, and test kits to facilitate the deep transfer of related technologies into clinical practice [8]. Group 3: Industry Collaboration and Talent Development - Successful technology commercialization relies on collaboration among clinical needs, market implementation by enterprises, technical problem-solving by research teams, and support from government departments [10]. - The establishment of the Tianjin Bio-Mass Spectrometry High-end Medical Equipment Innovation Consortium in 2023 aims to promote high-quality development of mass spectrometry technology through collaboration among universities, hospitals, and enterprises [10]. - The team is cultivating talent with a focus on the intersection of drug analysis and instrument technology, addressing the growing demand for professionals in clinical mass spectrometry and rational drug use monitoring [10]. Group 4: Future Prospects and Impact - The establishment of the mass spectrometry database is seen as a foundational step in creating a quantifiable and codified identity for complex TCM systems, which is crucial for shifting research paradigms [6]. - The integration of mass spectrometry databases, metabolomics, and clinical detection technologies is expected to enhance the scientific evaluation system of TCM, supporting its internationalization and industrial upgrading [11].